cache/21714b257ec73454e2abec4f4acb4a1133a21eb96f2767923506665309003a26

COM:C3INDUSTRIES

C3 Industries

  • Privately Held

Company Overview

Metric
Company NameC3 IndustriesCuraleaf Holdings, Inc.
SymbolCURA
MSH IDCOM:C3INDUSTRIESCOM:CURALEAF
MarketPRIVATESTOCKS
SectorConsumer ServicesHealthcare
IndustryCannabisDrug Manufacturers - Specialty & Generic
CountryUSUS
Stage
Employee Count5015.65K
Websitec3industries.comcuraleaf.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap2.70B
Enterprise Value
Monthly Web Traffic6.68K2.08M
Web Traffic Growth-0.25-0.40
Valuation
Raised Capital

Financial Performance

Metric
Revenue1.82B
Revenue (LTM)
Revenue (NTM)
Gross Profit644.70M
EBITDA343.90M
Operating Income57.88M
Net Income-379.53M
EPS-0.52
Diluted EPS-0.52
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.38
Operating Profit Margin0.04
EBITDA Margin0.19
Net Profit Margin-0.19
Return on Equity-0.25
Return on Assets-0.09
Return on Capital Employed0.02

Valuation Multiples

Metric
P/E Ratio-6.35
P/B Ratio1.71
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio1.37
EV Multiple4.89

Operational Metrics

Metric
Days Sales Outstanding18.73
Days Payables Outstanding30.85
Days Inventory Outstanding90.60
Operating Cycle109.33
Cash Conversion Cycle78.48
Asset Turnover0.56

Cash Flow Metrics

Metric
Operating Cash Flow101.58M
Free Cash Flow6.69M
Cash Flow to Debt0.18
Operating Cash Flow/Sales0.09
Free Cash Flow Yield0.02

Balance Sheet Metrics

Metric
Cash & Equivalents121.07M
Accounts Receivable148.47K
Inventory284.70M
Goodwill826.27M
Debt to Capitalization0.46
Debt to Assets0.20
Current Ratio0.72
Quick Ratio0.50

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.01
R&D to Revenue
SG&A to Revenue0.21